SynthesisPharmacotherapy2019

Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA-B*5701 Screening as a Risk-Mitigation Measure.

Chris M Stainsby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.